Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors.
Corbett JW, Ko SS, Rodgers JD, Gearhart LA, Magnus NA, Bacheler LT, Diamond S, Jeffrey S, Klabe RM, Cordova BC, Garber S, Logue K, Trainor GL, Anderson PS, Erickson-Viitanen SK.
Corbett JW, et al.
J Med Chem. 2000 May 18;43(10):2019-30. doi: 10.1021/jm990580e.
J Med Chem. 2000.
PMID: 10821714